Constance, Germany

David Szamosvari


 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: David Szamosvari: Innovator in Pathogenic Infection Solutions

Introduction

David Szamosvari is a notable inventor based in Constance, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at combating pathogenic infections. With a total of 2 patents to his name, Szamosvari's work is paving the way for innovative treatments in medicine.

Latest Patents

Szamosvari's latest patents include a compound designed for use against pathogenic species. This invention focuses on preventing and treating infections caused by pathogens, specifically targeting bacteria such as gonococcus and meningococcus. Additionally, it encompasses a pharmaceutical composition that utilizes this compound for disinfecting surfaces contaminated with these harmful bacteria. His second patent involves compounds that serve as both anti-bacterial and anti-fungal agents, as well as zinc sensors. This invention also includes a pharmaceutical composition and methods for treating bacterial or fungal infections in mammals.

Career Highlights

David Szamosvari is affiliated with the University of Konstanz, where he continues to engage in research and development. His work is characterized by a commitment to addressing critical health challenges through innovative solutions.

Collaborations

Some of his notable coworkers include Thomas Böttcher and Valentin Frederik Reichle, who contribute to the collaborative efforts in research and development at the university.

Conclusion

David Szamosvari's contributions to the field of pharmaceuticals highlight his dedication to innovation in combating pathogenic infections. His patents reflect a significant advancement in medical treatments, showcasing the potential for improved health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…